BTAI
BioXcel Therapeutics (BTAI)
$34
About BioXcel Therapeutics (BTAI)
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Details
Daily high
$0.34
Daily low
$0.30
Price at open
$0.30
52 Week High
$4.17
52 Week Low
$0.30
Market cap
16.9M
Dividend yield
0.00%
Volume
825,573
Avg. volume
960,807
P/E ratio
-.16
BioXcel Therapeutics News
Details
Daily high
$0.34
Daily low
$0.30
Price at open
$0.30
52 Week High
$4.17
52 Week Low
$0.30
Market cap
16.9M
Dividend yield
0.00%
Volume
825,573
Avg. volume
960,807
P/E ratio
-.16